Skip to main content
PLOS One logoLink to PLOS One
. 2015 Sep 29;10(9):e0139243. doi: 10.1371/journal.pone.0139243

KCa3.1-Dependent Hyperpolarization Enhances Intracellular Ca2+ Signaling Induced by fMLF in Differentiated U937 Cells

Antonello Penna 1, Andrés Stutzin 1,*
Editor: Randall Lee Rasmusson2
PMCID: PMC4587941  PMID: 26418693

Abstract

Formylated peptides are chemotactic agents generated by pathogens. The most relevant peptide is fMLF (formyl-Met-Leu-Phe) which participates in several immune functions, such as chemotaxis, phagocytosis, cytokine release and generation of reactive oxygen species. In macrophages fMLF-dependent responses are dependent on both, an increase in intracellular calcium concentration and on a hyperpolarization of the membrane potential. However, the molecular entity underlying this hyperpolarization remains unknown and it is not clear whether changes in membrane potential are linked to the increase in intracellular Ca2+. In this study, differentiated U937 cells, as a macrophage-like cell model, was used to characterize the fMLF response using electrophysiological and Ca2+ imaging techniques. We demonstrate by means of pharmacological and molecular biology tools that fMLF induces a Ca2+-dependent hyperpolarization via activation of the K+ channel KCa3.1 and thus, enhancing fMLF-induced intracellular Ca2+ increase through an amplification of the driving force for Ca2+ entry. Consequently, enhanced Ca2+ influx would in turn lengthen the hyperpolarization, operating as a positive feedback mechanism for fMLF-induced Ca2+ signaling.

Introduction

Formylated peptides are by-products produced by pathogens capable to induce immune cell chemotaxis during an immune response [1, 2]. The most relevant formylated peptide is fMLF (formyl-Met-Leu-Phe) produced mainly by Escherichia coli [3]. fMLF stimulates formylated peptide receptor 1 (FPR1) with high affinity (EC50 = 0.1–1 nM) and formylated peptide receptor 2 (FPR2) with low affinity (EC50 = 1 mM) [1, 2] triggering downstream activation of Gαi and Gβγ subunits [1, 2, 4] and thus, promoting several cellular functions aimed to eliminate pathogens, such as chemotaxis, phagocytosis, cytokine release and generation of reactive oxygen species [2, 5, 6].

fMLF-dependent effects in macrophages and neutrophils are mediated by an increase in intracellular calcium concentration ([Ca2+]i) [79] and by changes in the membrane potential (Vm) [10, 11]. fMLF increases [Ca2+]i by activating IP3 receptors causing Ca2+ release from intracellular reservoirs [7, 12]. On the other hand, it has been reported that fMLF hyperpolarizes Vm (-15 to -60 mV) in macrophages [10]. This hyperpolarization has been also observed in neutrophils and was found to be dependent on a Ca2+-activated K+ channel [13, 14]. However, the molecular entity underlying this hyperpolarization remains unknown. Moreover, from a mechanistic point of view it is not clear whether changes in Vm increases further [Ca2+]i by modulating the driving force for Ca2+ entry.

The intermediate-conductance Ca2+-activated K+ channel KCa3.1 [1517] is expressed in immune cells [1820]. This channel is activated by an increase in [Ca2+]i leading to an hyperpolarization of the Vm [21]. In macrophages, a KCa3.1-dependent hyperpolarization triggered by external ATP and mediated by an increase in [Ca2+]i has been previously described [20]. Similarly, in microglia KCa3.1 activation occurs by P2Y2 receptor stimulation triggering intracellular Ca2+ signaling [22]. Thus, KCa3.1 appears as a molecular candidate responsible for the hyperpolarization induced by fMLF. In this study, we used differentiated U937 cells as a macrophage cell model, to characterize the fMLF response. We determined that KCa3.1 is indeed responsible for the fMLF-induced hyperpolarization and modulation of the driving force for Ca2+ entry.

Material and Methods

Cell culture

The U937 cell line from American Type Cell Culture (ATCC, Catalogue CRL-1593.2) was kindly provided to us by C. Allers, Universidad del Desarrollo, Santiago, Chile. Cells were grown as a cellular suspension at 37°C and humidified 5% CO2 atmosphere in RPMI 1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco) and 100 units/mL penicillin-streptomycin (HyClone, Waltham, MA, USA). Cells were maintained at a concentration of 0.5x106 to 5x106 cells/mL and three times per week the medium was changed. Differentiation of U937 cells was induced with dibutyryl cAMP [23, 24]. Cells (0.3–0.5x106 cells/mL) were incubated with 1 mM of dibutyryl cAMP for 48 h resulting in mature adherent monocytes expressing FPR [24]. After 48 h cells were washed with PBS and were maintained in RPMI 1640 medium until experiments were performed (on the same day).

KCa3.1 knock down

KCa3.1 knockdown was achieved by infecting U937 cells with a set of three different lentiviral particles carrying GFP-tagged human KCNN4 shRNA (catalogue number VSH6286-00EG3783, GE Healthcare Dharmacon, Inc., Chicago, IL, USA). Cells were infected as indicated by the manufacturer. Selection was achieved with puromycin electrophysiological experiments were performed in green cells one week after infection.

Electrophysiological measurements

Nystatin perforated patch-clamp experiments were performed after 48 h of differentiation. Cells were plated on 12-mm coverslips and directly mounted on a chamber (RC-25, Warner Instruments Corp., Hamden CT, USA) fitted on the stage of an inverted microscope (Diaphot, Nikon Inc., Melville, NY,USA). Internal pipette solution contained (in mM): NaCl 5, KCl 140, MgCl2 1, HEPES 10 and pH 7.2 adjusted with TRIS, nystatin 165 μg/mL was freshly prepared and added to the pipette solution. For the experiment depicted in S2 Fig the pipette solution was modified replacing 140 mM KCl with 140 mM CsCl. The bath solution contained (in mM): NaCl 140, KCl 5, MgCl2 1, CaCl2 2, HEPES 10, D-glucose 10 and pH 7.4 adjusted with NaOH. The low Na+ bath solution used contained (in mM): NaCl 5, NMDGCl 100, KCl 5, MgCl2 1, CaCl2 2, HEPES 10, sorbitol 50, D-glucose 10 and pH 7.4 adjusted with NaOH. The 105 mM K+ solution contained (in mM): NaCl 5, KCl 105, MgCl2 1, CaCl2 2, HEPES 10, sorbitol 50, D-glucose 10 and pH 7.4 adjusted with NaOH. The bath solution without Ca2+ was prepared adding 5 mM EGTA in absence of CaCl2. The 65 mM K+ solution was prepared adding 65 mM KCl and 80 mM NaCl. Bath solutions were changed by a gravity-fed perfusion system and the solution level in the chamber was kept constant by a peristaltic pump. Voltage- and current-clamp experiments were recorded with EPC-7 amplifier (List-Medical, Darmstadt, Germany). Data were digitized at 10 kHz and low-pass filtered at 1 kHz. pClamp 8.0 software (Molecular Device Corp., Sunnyvale, CA, USA) was used for data acquisition and analysis. Patch electrodes (4 MΩ resistance) were pulled from borosilicate glass (Warner Instruments) using a BB-CH puller (Mecanex SA, Geneva, Switzerland). All experiments were performed at room temperature.

Calcium measurements

Intracellular Ca2+ concentration changes were measured using the Ca2+ indicators Fluo-3 AM, Fluo-4 AM and Indo-1 AM (Invitrogen, Waltham, MA, USA), as indicated in the figures. U937 cells after 48 h of differentiation were incubated with 2 μM of the given indicators dissolved in RPMI 1640 without FBS for 30 min in the dark at 37°C. Cells were then kept for 30 min in the presence of RPMI 1640 with 10% FBS in the dark. U937 cells were washed 2 times with PBS and suspended or bathed with the same solutions used and described for the electrophysiological measurements. Cells were exposed to the different drugs, [K+], EGTA or control conditions for approximately 5 min before starting the fluorescence measurements. fMLF was perfused throughout the experiments as shown in each figure. Fluorescence was measured using three different systems depending on the type of experiment and Ca2+ indicator used. Sinergy 2 multi-mode microplate reader (BioTek, Winooski, VT, USA) was used to measured fluorescence changes in 50–100x103 U937 cells for each condition and acquisition was made using Gene5 Data Analysis software (BioTek). Disk Spinning Confocal Unit (Olympus Corp., Tokyo, Japan) was used to quantify fluorescence changes in the cytoplasm of U937 cells and Cell v2.8 software (Olympus Corp.) was used for acquisition. Two fluorometers were used to measured fluorescence changes in U937 cells incubated with Indo-1 AM and acquisition was performed with AxoScope 8.2 software (Molecular Devices). For Fluo-3 and Fluo-4 the cells were excited at 485 nm and emission was detected at 520 nm. Fluorescence changes were expressed as (Ft-F0)/F0, where Ft was the fluorescence at any time and F0 was the basal fluorescence during 2 min before stimulus. For Indo-1 cells were excited at 340 nm and the acquisition was made at 405 nm and 485 nm. Fluorescence changes were expressed as the ratio 405/485 and the results were expressed as R1/R0, where R1 was the ratio at any time and R0 was the basal ratio during 2 min before stimulus.

Reagents

All reagents were of analytical grade and were purchased from Sigma (St. Louis, MO, USA) and Merck (Darmstadt, Germany). fMLF and dibutyryl cAMP were purchased from Sigma (St. Louis, MO, USA) and dissolved in DMSO.

Statistics

Data are represented as mean ± SEM. Unpaired Student’s t test was used to compare between two groups. For comparing three or more groups, one-way analysis of variance (ANOVA) followed by Bonferroni's post-hoc test was used. Statistical significance was set at p < 0.05.

Results

fMLF increases [Ca2+]i and hyperpolarizes U937 cells

To monitor changes in [Ca2+]i induced by fMLF, differentiated U937 cells were loaded with Fluo-3. As depicted in Fig 1A, fMLF (100 nM) in the presence of 2 mM external Ca2+ induced a rapid increase in intracellular Ca2+ followed by a slower decay phase. Under 0 external Ca2+ conditions (no Ca2+ added + 5 mM EGTA) the slower decay phase disappears. As shown in Fig 1B left panel, normalized peak fMLF-induced increase in [Ca2+]i in the absence of external Ca2+ was not different to that observed with a solution containing 2 mM Ca2+. However, the normalized area under the curve (AUC) for Ca2+ increase was 94% reduced in the absence of external Ca2+ (Fig 1B right panel).

Fig 1. fMLF increases [Ca2+]i and hyperpolarizes U937 cells.

Fig 1

A. Average of Fluo-3 recordings in U937 cells in the presence of 2 mM Ca2+ (●) or absence of external Ca2+ plus 5 mM EGTA (○). fMLF (100 nM) was applied in the bath solution during the time indicated by the horizontal bar. B. Summarized data showing fMLF-induced maximum fluorescence increase in the presence or absence of external Ca2+ (Ca2+: 1.00 ± 0.16; 0 Ca2+: 0.73 ± 0.19, n = 8 and 6 for each condition, respectively, p > 0.05, left panel) and fMLF-induced AUC of the Ca2+ increase in the presence and absence of external Ca2+ (Ca2+: 1.00 ± 0.14; 0 Ca2+: 0.06 ± 0.02, n = 8 and 6 for each condition, respectively, *** p < 0.001, right panel). C. Representative traces of Vm recordings in U937 cells in a bath solution containing 2 mM Ca2+ (left panel) or in the absence of Ca2+ plus 5 mM EGTA (right panel). fMLF (100 nM) was applied during the time indicated by the horizontal bar. D. Summarized data showing fMLF-induced Vm changes in 2 mM of Ca2+ or in the absence of Ca2+ (Resting: -13.2 ± 2 mV (Ca2+) and -17.0 ± 3 mV (0 Ca2+); fMLF: -71.1 ± 2 mV (Ca2+) and -68.8 ± 3 mV (0 Ca2+); Recovery: -14.0 ± 3 mV (Ca2+) and -14.0 ± 5 mV (0 Ca2+), n = 3–22 for each condition, left panel) and the duration of fMLF-induced hyperpolarization in the presence or absence of external Ca2+ (Ca2+: 7.9 ± 2 min; 0 Ca2+: 1.8 ± 1 min, n = 15 and 4, respectively, * p < 0.05, right panel). E and F. Representative traces of Fluo-3 (E) and Vm (F) records in U937 cells stimulated with 100 nM fMLF as indicated by the horizontal bars. The cells were initially bathed without Ca2+ plus 5 mM EGTA and afterward bathed with a solution containing 2 mM Ca2+ as indicated by horizontal bar.

As previously reported, fMLF hyperpolarizes the transmembrane potential (Vm) in macrophages [10]. Thus, we asked whether fMLF induces changes in Vm in differentiated U937 cells. Fig 1C depicts representative current clamp records in the presence of 2 mM external Ca2+ (left panel) or 0 external Ca2+ conditions (right panel). As shown, cells responded with a rapid (Ca2+: -0.131 ± 0.019 mV/ms; 0 Ca2+: -0.079 ± 0.005 mV/ms) hyperpolarization upon exposure to 100 nM fMLF reaching ~ -70 mV. Despite continuous exposure to fMLF Vm repolarizes rapidly after approximately 8 min. However, in the absence of external Ca2+ the duration of the hyperpolarization was 4-fold shorter (left panel) without a significant difference in the peak Vm reached. Fig 1D shows an average of the data from experiments similar to those shown in Fig 1C. Of note, in non-differentiated U937 cells (i.e. not treated with dibutyryl cAMP), fMLF was unable to induce changes in intracellular Ca2+ and Vm (S1 Fig), suggesting that the observed effect is dependent upon expression of the FPR as it has been shown that non-differentiated U937 cells do not express them [24].

To determine whether the [Ca2+]i increase and hyperpolarization induced by fMLF followed a similar time course, differentiated U937 cells were exposed to fMLF (100 nM) in the absence of external Ca2+ for >5 min, then bathed with a solution containing 2 mM Ca2+. As depicted in Fig 1E and 1F, transient increase in [Ca2+]i and hyperpolarization followed a similar temporal course, suggesting that both cellular responses might be linked by a common molecular mechanism.

fMLF-dependent hyperpolarization is secondary to a Ca2+-dependent K+ conductance

Because fMLF treatment changed Vm to a value compatible with the reversal potential for K+ (EK+), we studied whether a K+ conductance underlies the fMLF-induced hyperpolarization. Fig 2A shows a representative voltage-clamp record of an experiment performed to determine the ionic nature of the hyperpolarizing current. To that end, differentiated U937 cells were stimulated with 100 nM fMLF and the current was recorded at EK+ (-85 mV) and ECl- (4 mV), alternately. Therefore, if fMLF activates a K+ current, this current has to be observed at 4 mV. We observed an outwardly directed current of 33.20 ± 4.59 pA/pF at 4 mV. Furthermore, this current was completely abolished when cells were exposed to a bath solution containing 105 mM K+, which modified EK+ to a value close to 4 mV. Next, to confirm whether a K+ conductance underlies this hyperpolarization, we performed current clamp experiments, as shown by a representative current clamp record in Fig 2B. Cells where first exposed to 100 nM fMLF in a high-K+ (65 mM) external solution and then to a normal-K+ (5 mM) external solution. As shown, fMLF produced a small and brief hyperpolarization in high-K+ conditions, whereas under normal-K+ conditions a robust hyperpolarization was recorded. Furthermore, experiments performed with external tetraethylammonium (TEA 20 mM) and 140 mM internal Cs+ in order to block K+ conductances, yielded the same result as observed under external high-K+ conditions (S2 Fig).

Fig 2. fMLF-dependent hyperpolarization is secondary to a Ca2+-dependent K+ conductance.

Fig 2

A. Representative trace of a voltage-clamp recording showing the current density at -85 mV (○) and 4 mV (●) in U937 cells. Currents were measured using a holding potential of -30 mV and pulsing to -85 mV or 4 mV in square pulses of 0.5 s. The period for this pulse protocol was 2.5 s. Horizontal bar and black line indicate perfusion with 100 nM fMLF and a bath solution containing 105 mM K+, respectively. B. Representative trace of a current-clamp record showing Vm changes in U937 cells. Horizontal bar and black lines indicate perfusion with 100 nM fMLF and a bath solution containing 65 mM K+, respectively. C and D. Voltage-clamp recordings showing the currents at 4 mV in non-treated (C) and treated (D) U937 cells with 1 μM thapsigargin 5 min before exposure to fMLF. Same as 1E and 1F; cells were sequentially bathed without Ca2+ plus 5 mM EGTA and a solution containing 2 mM Ca2+ as indicated by horizontal bars.

Because the fMLF-induced hyperpolarization was found to be dependent on [Ca2+]i as well as the similarity of the time course of Ca2+ and Vm changes, we hypothesized that the K+ conductance activated upon fMLF exposure should be also Ca2+ dependent. Fig 2C and 2D depict representative voltage-clamp recordings designed to study the Ca2+ dependence of the K+ current. In the absence of external Ca2+, the K+ current was briefly activated by fMLF (100 nM) and was reactivated upon reintroduction of 2 mM Ca2+ (Fig 2C). In addition, after depletion of intracellular Ca2+ reservoirs with thapsigargin (1 μM), activation of the K+ current upon fMLF exposure was not detected in the absence of external Ca2+. However, upon external Ca2+ reintroduction, the K+ current was rapidly activated (Fig 2D).

KCa3.1 is the K+ conductance activated by fMLF in U937 cells

Immune cells express the intermediate and small-conductance Ca2+-dependent potassium channels (KCa) [19, 20, 2527]. To determine which KCa is activated by fMLF in U937 cells, we used a pharmacological approach. The intermediate-conductance KCa channel (KCa3.1) is blocked specifically and with high affinity (nanomolar range) by TRAM-34 and non-specifically by charybdotoxin and clotrimazole and is potentiated by DC-EBIO [28]. On the other hand, the small-conductance KCa channels (KCa2.1, KCa2.2 and KCa2.3) are insensible to TRAM-34, charybdotoxin and clotrimazole, although enhanced by DC-EBIO [28]. Fig 3A show current traces recorded with a voltage-clamp ramp protocol (-100 to 100 mV) in U937 cells. As depicted (left panel), the current elicited by fMLF (Erev -78.5 mV; EK+ -85 mV) was blocked (64%) by 100 nM TRAM-34 and potentiated (35%) by 10 μM DC-EBIO (right panel), suggesting that the molecular entity underlying fMLF-induced K+ conductance in these cells is KCa3.1. Fig 3B summarizes the effect of KCa blockers and DC-EBIO on the K+ current elicited by fMLF in U937 cells. We next tested whether intracellular Ca2+ could directly activate currents in U937 cells. To that end, conventional whole cell experiments were performed with 1 μM Ca2+ in the pipette solution. Fig 3C depicts representative current traces elicited by a ramp protocol (-100 to 60 mV) in the presence and absence of 10 μM clotrimazole. As shown, clotrimazole inhibited the Ca2+-activated current, confirming the presence of a Ca2+-activated K+ current in these cells. For unambiguous identification of the molecular identity of this Ca2+-activated K+ current, we performed knock down experiments. Using the same experimental conditions as described above, lentiviral transduced cells with either a control sh (scrambled sequence) or a set of three KCa3.1-targeted sh were used. As depicted in Fig 3D and 3E, the Ca2+-activated current K+ induced by 1 μM intracellular Ca2+ was decreased in cells carrying the shKCa3.1. Furthermore, as shown in Fig 3F fMLF-induced hyperpolarization was blunted in shKCa3.1 cells.

Fig 3. KCa3.1 is the K+ conductance activated by fMLF in U937 cells.

Fig 3

A. Current traces recorded with a voltage-clamp ramp protocol (-100 to 100 mV) in U937 cells previous (pre) and after exposure (post) to 100 nM TRAM-34 (left panel) and 10 μM DC-EBIO (right panel). B. Summarized pharmacological data showing the effects of blockers and DC-EBIO after fMLF-induced current has reached a stable magnitude. (TRAM-34, 100 nM: 36 ± 7%; charybdotoxin, 100 nM: 40 ± 9%; clotrimazole, 10 μM: 9 ± 3%; and DC-EBIO, 10 μM: 135 ± 10% of the control current; n = 3–5 for each condition, one-way ANOVA, Bonferroni's post-hoc test, *** p < 0.001). C. Representative currents traces of the Ca2+-activated current (1 μM Ca2+ in the pipette) elicited by a ramp protocol (-100 to 60 mV) under control conditions (pre) and after exposure to 10 μM clotrimazole (post). D. Representative currents traces of the Ca2+-activated current (1 μM Ca2+ in the pipette) elicited by a ramp protocol (-100 to 60 mV) in sh-control (shControl) and sh-KCa3.1 U937 cells (shKCa3.1). E. Summarized data showing the effect of KCa3.1 knock down in Ca2+-induced K+ currents (shControl: 11.7 ± 1.3 pA/pF; shKCa3.1: 5.8 ± 1.5 pA/pF, n = 3–4 for each condition, respectively, * p < 0.05). F. Summarized data of the effect of KCa3.1 knock down on fMLF-induced (100 nM) changes in membrane potential measured using the nystatin perforated patch-clamp technique (shControl: -62.3 ± 6 mV; shKCa3.1: -23.5 ± 3.8 pA/pF, n = 4 for each condition, ** p < 0.01).

KCa3.1 operates as a positive feedback mechanism for intracellular Ca2+ increase

Finally, we explored whether the hyperpolarization mediated by KCa3.1 enhances the increase in [Ca2+]i, by modifying the driving force for Ca2+ influx. Fig 4 displays intracellular Ca2+ monitoring experiments showing the effect of TRAM-34 and external high-K+ on fMLF-induced Ca2+ i dynamics. Fig 4A depicts the Ca2+ i time course (left panel) and the normalized AUC (right panel) in normal K+ (5 mM) and high-K+ (65 mM, calculated EK+ -20 mV) external solutions. As shown, fMLF-induced Ca2+ i increase is reduced (~49%) in high-K+. On the other hand, 1 μM TRAM-34 inhibited (~29%) fMLF-induced Ca2+ i increase (Fig 4B, left and right panel). Furthermore, TRAM-34 prevented fMLF-induced hyperpolarization (S3 Fig). In the absence of external Ca2+ the increase in [Ca2+]i was not affected by TRAM-34 (Fig 4C, left and right panel), indicating that KCa3.1-dependent hyperpolarization induced by fMLF enhances the increase of [Ca2+]i by an augmented Ca2+ influx.

Fig 4. KCa3.1 operates as a positive feedback mechanism for intracellular Ca2+ increase.

Fig 4

Average of Fluo-4 records during fMLF treatment (left panels) and AUC of fMLF-induced Ca2+ increase (right panels) in U937 cells in three different conditions. A. Cells were treated with fMLF in the presence of 5 mM (●) or 65 mM (○) external K+. AUC was 1 ± 0.14 with 5 mM K+ and 0.51 ± 0.04 with 65 mM K+ (n = 3, * p < 0.05). B and C. Cells were exposed to 1 μM TRAM-34 (○) or control condition (CON, ●). AUC was calculated both in CON and two different concentrations of TRAM-34 (0.1 and 1 μM). In (B), AUC was determined in the presence of 2 mM Ca2+ (CON: 1 ± 0.04; TRAM-34, 0.1 μM: 0.96 ± 0.04; TRAM-34, 1 μM: 0.71 ± 0.07, n = 6, one-way ANOVA Bonferroni's post hoc test, ** p < 0.01). In (C), AUC was measured in the absence of Ca2+ plus 5 mM EGTA (CON: 1 ± 0.04; TRAM-34, 0.1 μM: 1.1 ± 0.03; TRAM-34, 1 μM: 1.1 ± 0.05, n = 6).

Discussion

In this study, we demonstrate that fMLF induces in differentiated human U937 cells a Ca2+-dependent hyperpolarization via activation of the K+ channel KCa3.1. In addition, we found that this hyperpolarization enhances fMLF-induced intracellular Ca2+ increase through an amplification of the driving force for Ca2+ entry. Consequently, enhanced Ca2+ influx would in turn lengthen hyperpolarization, operating as a positive feedback mechanism for fMLF-induced signaling.

Our data demonstrate that plasma membrane hyperpolarization induced by fMLF in U937 cells is due to the activation of a K+ current as Vm reaches -71 mV, a value close to the EK + (-85 mV). In addition, when [K+]e is increased to 65 mM, which changes EK + to -20 mV, the magnitude of the hyperpolarization is significantly decreased. We also found that this K+ conductance corresponds to a Ca2+-dependent K+ channel because the activation of the current follows the same temporal course of the intracellular Ca2+ increase. Also, absence of Ca2+ influx and inhibition of Ca2+ release from intracellular reservoirs hindered the activation of the fMLF-induced K+ conductance. Finally, based on the pharmacological profile (inhibition by TRAM-34 and potentiation by DC-EBIO) [28, 29] as well as functional knock down we identified, for the first time, KCa3.1 as the molecular entity responsible for fMLF-induced K+ current in macrophage-like differentiated U937 cells.

fMLF-induced Ca2+ increase occurs via release from intracellular reservoirs and Ca2+ influx. Several studies report that upon fMLF binding to its receptor Ca2+ is released from intracellular reservoirs trough IP3 receptor activation [4, 7, 12]. This release promotes an initial, fast and transient increase in [Ca2+]i followed by a sustained phase dependent on Ca2+ influx. Although we did not explore the molecular entities underlying fMLF-induced Ca2+ entry, it is interesting to note that clotrimazole is almost 3-fold more effective in reducing fMLF-induced Ca2+ increase than TRAM-34, a value similar to that observed under 0 external Ca2+ plus EGTA. The robust effect of clotrimazole on the Ca2+ increase (S4 Fig) could be explained by the fact that clotrimazole besides blocking K+ conductances also blocks TRPM2, known to be expressed in U937 cells [30], in the same dose range [28, 31]. In addition, store operated channel entry (SOCE) might play a role in the influx of Ca2+, as KCa3.1 and SOCE are known to be tightly coupled in human macrophages [32].

Immune cell function depends on the magnitude and duration of the increase in the [Ca2+]i [12, 33]. The driving force for Ca2+ entry is a critical factor to boost Ca2+ signaling. In our experiments, fMLF shifts Vm from -13 mV to -71 mV, implying roughly a 44% increase in the driving force for Ca2+ entry. Because KCa3.1 is responsible for the hyperpolarization and, consequently, the increase in the driving force, the inhibition of this channel significantly decreases intracellular Ca2+ increase. This decrease occurs only in the presence of external Ca2+, indicating that Ca2+ entry is decreased by a reduction in the driving force. In fact, we observed that in the presence of external Ca2+ KCa3.1 inhibition by 1 μM TRAM-34 decreased fMLF-induced Ca2+ increase by 29% (Fig 4B). Interestingly, a similar result was observed in microglial cells, in which KCa3.1 inhibition by TRAM-34 (1 μM) was found to reduce the increase of Ca2+ i triggered by extracellular UTP in approximately 30% [22].

As mentioned above KCa3.1 has a role in the Ca2+ signaling induced by fMLF. Thus, the maximal effect of the KCa3.1 blocker on Ca2+ signaling should be observed at a concentration sufficient to abolish fMLF-dependent hyperpolarization. However, we observed that to block the fMLF-induced hyperpolarization 0.1 μM TRAM-34 was enough, while the increase in the [Ca2+]i triggered by fMLF was only significantly diminished with 1 μM TRAM-34. Despite the inconsistency regarding the concentration required to block fMLF-induced hyperpolarization and Ca2+ increase, our results do support a relevant role of KCa3.1. It should be noted that fMLF-induced Ca2+ signaling was diminished by 49% when hyperpolarization was prevented by increasing [K+]e, which confirms that half of the increase in the [Ca2+]i is mediated by a K+-dependent hyperpolarization. Also, although TRAM-34 at 1 μM is still considered a specific blocker of KCa3.1, at this concentration TRAM-34 could block other voltage-gated K+ channels, which have an IC50 of approximately 5 μM [29]. Therefore, it can be concluded that the effect of TRAM-34 on Ca2+ signaling is mediated by KCa3.1, although we can not discard the role of other K+ channels.

It has been previously shown that KCa3.1 plays several roles in the immune response [3436]. For example, KCa3.1 facilitates mast cell degranulation in mice [35], migration of dendritic cells [34] and promotes atherogenesis in mice due to an infiltration by macrophages and T lymphocytes in plaques [36]. All of the above mentioned processes share a common mechanism; an enhancement in Ca2+ i increase by boosting the driving force for Ca2+ entry. Therefore, our study suggests that KCa3.1 might enhance chemotaxis, phagocytosis, reactive oxygen species as well as cytokine production in monocytes and macrophages upon stimulation with chemotactic peptides.

In summary, our data indicate that KCa3.1 is the molecular entity responsible for the hyperpolarization observed upon fMLF exposure in differentiated U937 cells, thereby controlling the driving force for Ca2+ entry and thus, modulating Ca2+ i signaling in these cells through a positive feedback mechanism.

Supporting Information

S1 Fig. Non-differentiated U937 cells do not respond to fMLF stimulation.

A and B. Representative Indo-1 (A) and Vm (B) recordings during fMLF treatment in non-differentiated U937 cells, 100 nM fMLF and 5 μM ionomycin (ION) were applied during the time indicated by the horizontal bars.

(EPS)

S2 Fig. Extracellular TEA plus intracellular Cs+ prevent fMLF-induced hyperpolarization in U937 cell.

Vm was recorded in a differentiated U937 cell in the presence of 20 mM TEA in the bath and 140 mM Cs+ in the pipette. Horizontal bar indicates exposure to 100 nM fMLF (n = 4).

(EPS)

S3 Fig. TRAM-34 prevents fMLF-induced hyperpolarization in U937 cells.

Vm recording obtained form a differentiated U937 cell in the presence of 100 nM TRAM-34 in the bath. Horizontal bar indicates exposure to 100 nM fMLF (n = 4).

(EPS)

S4 Fig. Clotrimazole decreases fMLF-induced Ca2+i increase in U937 cells.

A. Average of Indo-1 records performed in control conditions (●) or in the presence of 10 μM clotrimazole (○) in differentiated U937 cells. In both conditions cells were treated with 100 nM fMLF during the time indicated by the horizontal bar. B. AUC of fMLF-induced Ca2+ increase in control (black) or clotrimazole (empty) treatment (Control: 1 ± 0.16; clotrimazole, 10 μM: 0.22 ± 0.08, n = 6 and 3, respectively, * p < 0.05).

(EPS)

Acknowledgments

We are grateful to Rodrigo Alzamora for suggestions and critically reading the manuscript.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was funded by Fondecyt-FONDAP (Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias) (Chile) Grant Number 15010006, http://www.conicyt.cl/fondap/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Le Y, Oppenheim JJ, Wang JM. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 2001; 12: 91–105. [DOI] [PubMed] [Google Scholar]
  • 2. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009; 61: 119–161. 10.1124/pr.109.001578 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairn R, et al. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli . J Biol Chem. 1984; 259: 5430–5439. [PubMed] [Google Scholar]
  • 4. Rabiet MJ, Huet E, Boulay F. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie. 2007; 89: 1089–1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Bylund J, Samuelsson M, Collins LV, Karlsson A. NADPH-oxidase activation in murine neutrophils via formyl peptide receptors. Exp Cell Res. 2003; 282: 70–77. [DOI] [PubMed] [Google Scholar]
  • 6. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, Berton G. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol. 1992; 148: 3216–3220. [PubMed] [Google Scholar]
  • 7. Pettit EJ, Fay FS. Cytosolic free calcium and the cytoskeleton in the control of leukocyte chemotaxis. Physiol Rev. 1998; 78: 949–967. [DOI] [PubMed] [Google Scholar]
  • 8. Evans JH, Falke JJ. Ca2+ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages. Proc Natl Acad Sci USA. 2007; 104: 16176–16181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Brechard S, Tschirhart EJ. Regulation of superoxide production in neutrophils: role of calcium influx. J Leukoc Biol. 2008; 84: 1223–1237. 10.1189/jlb.0807553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Gallin EK, Gallin JI. Interaction of chemotactic factors with human macrophages. Induction of transmembrane potential changes. J Cell Biol. 1977; 75: 277–289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Ince C, Coremans JM, Ypey DL, Leijh PC, Verveen AA, van Furth R. Phagocytosis by human macrophages is accompanied by changes in ionic channel currents. J Cell Biol. 1988; 106: 1873–1878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Partida-Sánchez S, Cockayne DA, Monard S, Jacobson EL, Oppenheimer N, Garvy B, et al. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med. 2001; 7: 1209–1216. [DOI] [PubMed] [Google Scholar]
  • 13. Lazzari KG, Proto P, Simons ER. Neutrophil hyperpolarization in response to a chemotactic peptide. J Biol Chem. 1990; 265: 10959–10967. [PubMed] [Google Scholar]
  • 14. Seligmann BE, Gallin EK, Martin DL, Shain W, Gallin JI. Interaction of chemotactic factors with human polymorphonuclear leukocytes: studies using a membrane potential-sensitive cyanine dye. J Membr Biol. 1980; 52: 257–272. [DOI] [PubMed] [Google Scholar]
  • 15. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA. 1997; 94: 11651–11656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Joiner WJ, Wang LY, Tang MD, Kaczmarek LK. hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci USA. 1997; 94: 11013–11018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Logsdon NJ, Kang J, Togo JA, Christian EP, Aiyar J. A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J Biol Chem. 1997; 272: 32723–32726. [DOI] [PubMed] [Google Scholar]
  • 18. Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA, et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem. 2000; 275: 37137–37149. [DOI] [PubMed] [Google Scholar]
  • 19. Schmid-Antomarchi H, Schmid-Alliana A, Romey G, Ventura MA, Breittmayer V, Millet MA, et al. Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J Immunol. 1997; 159: 6209–6215. [PubMed] [Google Scholar]
  • 20. Hanley PJ, Musset B, Renigunta V, Limberg SH, Dalpke AH, Sus R, et al. Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc Natl Acad Sci USA. 2004; 101: 9479–9484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Neylon CB, Lang RJ, Fu Y, Bobik A, Reinhart PH. Molecular cloning and characterization of the intermediate-conductance Ca2+-activated K+ channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function. Circ Res. 1999; 85: e33–43. [DOI] [PubMed] [Google Scholar]
  • 22. Ferreira R, Schlichter LC. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca2+ signaling, store refilling and migration of rat microglial cells. PLoS One. 2013; 8: e62345 10.1371/journal.pone.0062345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Sheth B, Dransfield I, Partridge LJ, Barker MD, Burton DR. Dibutyryl cyclic AMP stimulation of a monocyte-like cell line, U937: a model for monocyte chemotaxis and Fc receptor-related functions. Immunology. 1988; 63: 483–490. [PMC free article] [PubMed] [Google Scholar]
  • 24. Kay GE, Lane BC, Snyderman R. Induction of selective biological responses to chemoattractants in a human monocyte-like cell line. Infect Immun. 1983; 41: 1166–1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Fay AJ, Qian X, Jan YN, Jan LY. SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. Proc Natl Acad Sci USA. 2006; 103: 17548–17553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Schlichter LC, Kaushal V, Moxon-Emre I, Sivagnanam V, Vincent C. The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro . J Neuroinflammation. 2010; 7: 4 10.1186/1742-2094-7-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Desai R, Peretz A, Idelson H, Lazarovici P, Attali B. Ca2+-activated K+ channels in human leukemic Jurkat T cells. Molecular cloning, biochemical and functional characterization. J Biol Chem. 2000; 275: 39954–39963. [DOI] [PubMed] [Google Scholar]
  • 28. Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem. 2007; 14: 1437–1457. [DOI] [PubMed] [Google Scholar]
  • 29. Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci USA. 2000; 97: 8151–8156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y, et al. TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med. 2008; 14: 738–747. 10.1038/nm1758 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Hill K, McNulty S, Randall AD. Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole. Naunyn Schmiedebergs Arch Pharmacol. 2004; 370: 227–237. [DOI] [PubMed] [Google Scholar]
  • 32. Gao YD, Hanley PJ, Rinne S, Zuzarte M, Daut J. Calcium-activated K(+) channel (K(Ca)3.1) activity during Ca(2+) store depletion and store-operated Ca(2+) entry in human macrophages. Cell calcium. 2010;48(1):19–27. 10.1016/j.ceca.2010.06.002 [DOI] [PubMed] [Google Scholar]
  • 33. Partida-Sánchez S, Iribarren P, Moreno-García ME, Gao JL, Murphy PM, Oppenheimer N, et al. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J Immunol. 2004; 172: 1896–1906. [DOI] [PubMed] [Google Scholar]
  • 34. Shao Z, Makinde TO, Agrawal DK. Calcium-activated potassium channel KCa3.1 in lung dendritic cell migration. Am J Respir Cell Mol Biol. 2011; 45: 962–968. 10.1165/rcmb.2010-0514OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Shumilina E, Lam RS, Wolbing F, Matzner N, Zemtsova IM, Sobiesiak M, et al. Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1. J Immunol. 2008; 180: 8040–8047. [DOI] [PubMed] [Google Scholar]
  • 36. Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, et al. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest. 2008; 118: 3025–3037. 10.1172/JCI30836 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Fig. Non-differentiated U937 cells do not respond to fMLF stimulation.

A and B. Representative Indo-1 (A) and Vm (B) recordings during fMLF treatment in non-differentiated U937 cells, 100 nM fMLF and 5 μM ionomycin (ION) were applied during the time indicated by the horizontal bars.

(EPS)

S2 Fig. Extracellular TEA plus intracellular Cs+ prevent fMLF-induced hyperpolarization in U937 cell.

Vm was recorded in a differentiated U937 cell in the presence of 20 mM TEA in the bath and 140 mM Cs+ in the pipette. Horizontal bar indicates exposure to 100 nM fMLF (n = 4).

(EPS)

S3 Fig. TRAM-34 prevents fMLF-induced hyperpolarization in U937 cells.

Vm recording obtained form a differentiated U937 cell in the presence of 100 nM TRAM-34 in the bath. Horizontal bar indicates exposure to 100 nM fMLF (n = 4).

(EPS)

S4 Fig. Clotrimazole decreases fMLF-induced Ca2+i increase in U937 cells.

A. Average of Indo-1 records performed in control conditions (●) or in the presence of 10 μM clotrimazole (○) in differentiated U937 cells. In both conditions cells were treated with 100 nM fMLF during the time indicated by the horizontal bar. B. AUC of fMLF-induced Ca2+ increase in control (black) or clotrimazole (empty) treatment (Control: 1 ± 0.16; clotrimazole, 10 μM: 0.22 ± 0.08, n = 6 and 3, respectively, * p < 0.05).

(EPS)

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES